Dramatic Growth Predicted for Global POC Testing Segment

The global point-of-care (POC) testing market will experience striking growth from US$12.8 billion in 2008 to $17.8 billion by 2014 according to a new report.

Distributed by Life Science Intelligence (LSI; Huntington Beach, CA, USA), the report provides a global analysis of the patients, procedures, technologies, and companies driving growth and innovation in the POC testing market. It is divided into three main segments: hospital bedside testing products; home and self-testing products; and physician's office lab products.

Each of these areas is divided by product and geography with detailed share-by-supplier information. Various factors contributing to the expected growth include: the demands of physicians for more efficient approaches to the delivery of care; demands for faster access to diagnostic test results to optimize patient outcomes in emergency and critical care settings; the development of advanced analytical technologies, including high-sensitivity assays suitable for POC use, as well as microfluidics technologies that enable highly sophisticated assays to be performed at the bedside by nonlaboratory personnel, with accuracy equivalent to that achieved in the central laboratory; and advanced computer and communications technologies that allow POC testing to be managed as effectively as tests performed in the central lab.

The report is based on a study that included more than 200 interviews with pathologists and laboratory directors; investigators and technical experts; and company presidents, marketing executives, and business development executives.

LSI delivers market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies) Database, EMT (Emerging Medical Technologies) Spotlight events, medtech market reports, and provides global custom research services.

Related Links:
Life Science Intelligence